Suntrust Banks’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $980K | Buy |
7,403
+665
| +10% | +$88K | 0.01% | 744 |
|
|
2019
Q2 | $956K | Buy |
6,738
+934
| +16% | +$133K | 0.01% | 785 |
|
|
2019
Q1 | $844K | Sell |
5,804
-2,651
| -31% | -$386K | ﹤0.01% | 803 |
|
|
2018
Q4 | $957K | Buy |
8,455
+123
| +1% | +$13.9K | 0.01% | 714 |
|
|
2018
Q3 | $1.12M | Buy |
8,332
+2,091
| +34% | +$281K | 0.01% | 715 |
|
|
2018
Q2 | $701K | Sell |
6,241
-45
| -0.7% | -$5.05K | ﹤0.01% | 820 |
|
|
2018
Q1 | $671K | Buy |
6,286
+751
| +14% | +$80.2K | ﹤0.01% | 815 |
|
|
2017
Q4 | $607K | Buy |
5,535
+183
| +3% | +$20.1K | ﹤0.01% | 823 |
|
|
2017
Q3 | $579K | Sell |
5,352
-156
| -3% | -$16.9K | ﹤0.01% | 844 |
|
|
2017
Q2 | $557K | Sell |
5,508
-408
| -7% | -$41.3K | ﹤0.01% | 816 |
|
|
2017
Q1 | $532K | Buy |
5,916
+196
| +3% | +$17.6K | ﹤0.01% | 817 |
|
|
2016
Q4 | $435K | Buy |
5,720
+12
| +0.2% | +$913 | ﹤0.01% | 1061 |
|
|
2016
Q3 | $475K | Sell |
5,708
-86
| -1% | -$7.16K | ﹤0.01% | 979 |
|
|
2016
Q2 | $477K | Buy |
5,794
+1,300
| +29% | +$107K | ﹤0.01% | 972 |
|
|
2016
Q1 | $340K | Sell |
4,494
-682
| -13% | -$51.6K | ﹤0.01% | 1073 |
|
|
2015
Q4 | $415K | Hold |
5,176
| – | – | ﹤0.01% | 1003 |
|
|
2015
Q3 | $327K | Hold |
5,176
| – | – | ﹤0.01% | 982 |
|
|
2015
Q2 | $363K | Sell |
5,176
-284
| -5% | -$19.9K | ﹤0.01% | 951 |
|
|
2015
Q1 | $432K | Hold |
5,460
| – | – | ﹤0.01% | 875 |
|
|
2014
Q4 | $347K | Sell |
5,460
-72
| -1% | -$4.58K | ﹤0.01% | 926 |
|
|
2014
Q3 | $329K | Sell |
5,532
-30
| -0.5% | -$1.78K | ﹤0.01% | 1124 |
|
|
2014
Q2 | $296K | Sell |
5,562
-7,239
| -57% | -$385K | ﹤0.01% | 1211 |
|
|
2014
Q1 | $770K | Buy |
12,801
+1,429
| +13% | +$86K | ﹤0.01% | 1101 |
|
|
2013
Q4 | $600K | Buy |
11,372
+1,417
| +14% | +$74.8K | ﹤0.01% | 1168 |
|
|
2013
Q3 | $458K | Buy |
9,955
+1,586
| +19% | +$73K | ﹤0.01% | 1269 |
|
|
2013
Q2 | $341K | Buy |
+8,369
| New | +$341K | ﹤0.01% | 1351 |
|